Clinicopathologic Comparison of Lynch Syndrome–associated and “Lynch-like” Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry
暂无分享,去创建一个
C. Moskaluk | M. Stoler | A. Mills | K. Atkins | S. Modesitt | E. Sloan | Martha H Thomas
[1] F. Gao,et al. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing. , 2015, Gynecologic oncology.
[2] R. Bennett,et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment , 2014, Genetics in Medicine.
[3] W. Frankel,et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.
[4] R. Pai,et al. Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer , 2014, The American journal of surgical pathology.
[5] Aung Ko Win,et al. Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome) , 2014, The application of clinical genetics.
[6] Randall W Burt,et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. , 2014, Diseases of the colon and rectum.
[7] C. Eng,et al. Equality in lynch syndrome screening: why should we hold patients with endometrial cancer to a different standard? , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Karnezis,et al. Association of Tumor Morphology With Mismatch-repair Protein Status in Older Endometrial Cancer Patients: Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome , 2014, The American journal of surgical pathology.
[9] Aung Ko Win,et al. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives , 2014, Gut.
[10] I. Nagtegaal,et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.
[11] J. Carethers. Differentiating Lynch-like from Lynch syndrome. , 2014, Gastroenterology.
[12] F. Aranda,et al. Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers , 2013, PloS one.
[13] C. Boland,et al. Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population , 2013, Familial Cancer.
[14] C. Eng,et al. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. , 2013, Gynecologic oncology.
[15] K. Atkins,et al. Women 50 Years Or Younger With Endometrial Cancer: The Argument for Universal Mismatch Repair Screening and Potential for Targeted Therapeutics , 2013, International Journal of Gynecologic Cancer.
[16] Á. Carracedo,et al. Risk of cancer in cases of suspected lynch syndrome without germline mutation. , 2013, Gastroenterology.
[17] D. Evans,et al. Cancer risk in Lynch Syndrome , 2013, Familial Cancer.
[18] F. Hu,et al. MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features , 2013, PloS one.
[19] M. Al-Hussaini,et al. Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked. , 2013, Archives of pathology & laboratory medicine.
[20] R. Kuiper,et al. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients , 2013, Familial Cancer.
[21] E. Kuipers,et al. Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. , 2012, Gynecologic oncology.
[22] Michael S. Rentz,et al. Immunohistochemical Staining for DNA Mismatch Repair Proteins in Intestinal Tract Carcinoma: How Reliable are Biopsy Samples? , 2011, The American journal of surgical pathology.
[23] A. Bateman,et al. DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material , 2010, Pathology.
[24] L. Tafe,et al. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms , 2010, Modern Pathology.
[25] P. Radice,et al. Lynch Syndrome—Related Endometrial Carcinomas Show a High Frequency of Nonendometrioid Types and of High FIGO Grade Endometrioid Types , 2010, International journal of surgical pathology.
[26] H. Hollema,et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome , 2009, Genes, chromosomes & cancer.
[27] K. Garg,et al. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma , 2009, Journal of Clinical Pathology.
[28] D. Evans,et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.
[29] Jeffrey R. Botkin,et al. Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .
[30] Jian-Min Chen. The 10‐Mb paracentric inversion of chromosome arm 2p in activating MSH2 and causing hereditary nonpolyposis colorectal cancer: Re‐annotation and mutational mechanisms , 2008, Genes, chromosomes & cancer.
[31] W. Frankel,et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.
[32] H. Morreau,et al. Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians , 2006, CA: a cancer journal for clinicians.
[33] R. Broaddus,et al. Pathologic features of endometrial carcinoma associated with HNPCC , 2006, Cancer.
[34] H C van Houwelingen,et al. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.
[35] W. Frankel,et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.
[36] M. Andreu,et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. , 2005, JAMA.
[37] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[38] H. Meijers-Heijboer,et al. Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer , 2004, Clinical Cancer Research.
[39] H. Morreau,et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. , 2003, The American journal of pathology.
[40] A. Wagner,et al. A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred , 2002, Genes, chromosomes & cancer.
[41] M. Loda,et al. Evaluation of Microsatellite Instability and Updated Version Cited Articles Citing Articles E-mail Alerts Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-line Msh2 and Mlh1 Mutations in Hereditary Nonpolyposis Colon Cancer Families , 2022 .
[42] M. Leppert,et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. , 2001, Gastroenterology.
[43] I. Tomlinson,et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer , 2001, Gut.
[44] B. Yildizhan,et al. Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium. , 2001, European journal of gynaecological oncology.
[45] Charis Eng,et al. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations inMSH2 and MLH1 , 2000, Journal of medical genetics.
[46] L. Aaltonen,et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] L. Aaltonen,et al. Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome , 1995, International journal of cancer.
[48] D. Herbold,et al. The significance of squamous differentiation in endometrial carcinoma , 1988 .
[49] W. Christopherson,et al. Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. A clinical-pathological study of 68 cases with long-term follow-up. , 1982, American journal of clinical pathology.
[50] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[51] S. Silverberg,et al. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium.A clinicopathologic study , 1972, Cancer.